Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-29 @ 10:13 PM
Study NCT ID:
NCT00780403
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Sponsor:
Organon and Co
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P04573
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None